Prophylactic Medium-Class Topical Steroids are Associated with a Lower Incidence of Capecitabine-Induced Hand-Foot Syndrome in Patients with Colorectal Cancer

Study limitation reported by the research below: “Group allocation was physician-directed, not randomized — confounding by indication cannot be ruled out despite multivariable adjustment.”